Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Noncontrolling Interest [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2022 $ 6 $ 19,189 $ (11,558) $ 7,637
Balance, shares at Dec. 31, 2022 5,577,916        
Net loss 7 (814) (807)
Restricted stock vesting 24 24
Restricted stock vesting, shares 5,682        
Exercise of warrants
Exercise of stock warrants, shares 30,430        
Non-controlling interest in JV 500 500
Balance at Mar. 31, 2023 $ 6 19,213 507 (12,372) 7,354
Balance, shares at Mar. 31, 2023 5,614,028        
Balance at Dec. 31, 2023 $ 6 19,406 469 (14,715) 5,166
Balance, shares at Dec. 31, 2023 5,741,838        
Share-based compensation and restricted stock vesting 54 54
Rights offering proceeds, net of expenses 946 946
Rights offering proceeds, net of expenses, shares 485,786        
Issuance of placement agent warrants in conjunction with the rights offering (56) (56)
Net loss (52) (853) $ (905)
Restricted stock vesting, shares         86,784
Balance at Mar. 31, 2024 $ 6 $ 20,350 $ 417 $ (15,568) $ 5,205
Balance, shares at Mar. 31, 2024 6,227,624